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Dino Moras1, Natacha Rochel1.
1IGBMC, Illkirch, France, 2CBS, Montpellier, France.
The nuclear receptor superfamily (NRs) comprises ligand-dependent transcrip-
tion regulators, many of which function as homodimers or heterodimers with
RXR. We show that addition of an SRC-1 coactivator-derived peptide to mo-
nomeric liganded retinoic acid receptor (RAR) promotes efficient homodimer
formation. X-ray crystallography revealed that homodimers are asymmetrical,
reminiscent of functional RXR-RAR heterodimers with distinct conformations
of ligand in the two subunits. A global switch to the dimeric state with
a 2RAR:1SRC-1 stoichiometry was also seen using a larger 20kDa domain
of SRC-1. Our study reveals an allosteric mechanism whereby coactivator
binding to one RAR partner affects ligand conformation and H12 position of
the second partner, hrough the dimer interface. A similar control on the recruit-
ment of SRC-1 is also observed with ER in the crystal structures of ERa bound
to agonist ligands and coactivator peptide.
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Jeff Reinking, Nicholas Dipaola, Kara DeSantis, Marissa Magerkurth,
Sarah Benkwitt, Aaron Reed.
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Identification of ligands that interact with nuclear receptors (NRs) is both a ma-
jor biological problem and an important initial step in drug discovery. Several
in vitro and in vivo techniques are commonly used to screen ligand candidates
against nuclear receptors, however none of the current assays allow screening
without modification of either the protein and/or the ligand in a high-
throughput fashion. Differential scanning fluorimetry (DSF) allows unmodi-
fied potential ligands to be screened as 10mL reactions in 96-well format
against partially purified protein, revealing specific interactors. As a proof of
principle, we used a commercially available NR ligand candidate chemical
library to identify interactors to several well characterized human NRs.
Compounds that interact specifically with NR Ligand Binding Domains stabi-
lize the protein and result in an elevation of the thermal denaturation point as
monitored by the environmentally sensitive dye SYPRO orange. We present
results validating DSF as a new tool for identifying NR ligands and screening
candidate compounds and also present results of orphan NRs currently under
investigation.
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The Mode of Action of FtsZ Inhibitors
Hettiarachchige D. Perera, Jessica Keffer, Carole Bewley.
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Multi-drug-resistant bacterial infection is the primary cause for death in the
world. Developing antimicrobial agents that act or inhibit through mechanisms
different than those of existing antibacterial drugs offer an advantage in that
resistance mutations will not have developed, and thus have a better prospect
to efficiently kill bacteria. Over the past decade, a significant advancement
has occurred in the use of FtsZ as a target for antimicrobial activity.
FtsZ is a highly conserved multimeric cytoskeleton protein in prokaryotes. It
forms a z-ring structure at the middle plane of the bacterial cell, in which
cooperation with other bacterial proteins eventually propagates cytokinesis.
Binding of GTP to the monomeric FtsZ protein promotes dimerization and pro-
tofilament formation. Affecting the GTPase activity of FtsZ will inhibit dimer-
ization/polymerization and subsequent z-ring formation and eventually inhibits
bacterial cell division. Therefore, FtsZ has become a promising target for the
development of antibacterial drugs.
Recent studies have revealed a number of natural and synthetic small mole-
cules, which target FtsZ and cause lethality in bacteria thus making FtsZ an ex-
cellent target for the development of broad-spectrum antimicrobial drugs.
These inhibitors are classified on the basis of the mode of action or by origin
as natural or synthetic inhibitors. Most inhibitors affect GTPase activity, sub-
sequently affecting cell division. Some inhibitors stabilize protofilaments,
which also affects the formation of the z-ring. Whatever mode of action, all
these inhibitors are lethal to bacteria. However, the mechanism of how various
types of inhibitors binds to FtsZ and eventually inhibits cell division is still to
be evaluated. In this study, we will demonstrate, for the first time, how and towhat site each inhibitor binds on FtsZ protein. Understanding of this mecha-
nism is crucial for the future development of antimicrobial drugs with high
efficacy.
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We have performed physicochemical and statistical analysis of a large dataset
of sequences of the V3 loop of the glycoprotein gp120 from HIV-1 strains with
known coreceptor selectivity, derived from patient data. The entry of HIV-1
into host cells is mediated by the interaction of the V3 loop of gp120 and cor-
eceptors CCR5 and CXCR4 on host cell surfaces, with the aid of viral protein
gp41 and cell receptor CD4. The choice of CCR5 for viral entry is associated
with the asymptomatic cell infection, whereas the choice of CXCR4 is associ-
ated with progression to disease. Given the sequence and structural variability
of the V3 loop, we have searched for persistent physicochemical properties that
may be mediators of coreceptor selectivity and binding using the Los Alamos
HIV Databases [1]. Our electrostatic analysis demonstrates that charge is the
dominant factor that mediates coreceptor selectivity, other factors being the
N6XT/SX9 glycosylation motif and the 11/24/25 rule. We have examined
amino acid propensities for each position of the V3 loop sequence and identi-
fied key amino acids and positions that may affect the coreceptor choice. We
have studied the conformational variability of the V3 loop, using molecular dy-
namics simulations, and identified persistent intramolecular interactions that
may be important for maintaining the electrostatic profile of the V3 loop that
facilitates coreceptor binding. We have used a statistical model to estimate
the probability for coreceptor selectivity, as a function of charge and presence
or absence of glycosylation motif and 11/24/25 rule. We present an integrated
predictive scheme of coreceptor selectivity and binding, which may be useful in
estimating disease progression, and perhaps aiding in tailoring the selection of
anti-HIV drugs for individual patients.
[1] http://www.hiv.lanl.gov/content/index.
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One of the two main drug targets in human immunodeficiency virus-1 (HIV-1)
therapy is the reverse transcriptase (RT) enzyme. Non-nucleoside RT inhibitors
(NNRTIs) are a class of highly specific drugs which bind to a pocket approx-
imately 10 A˚ from the polymerase active site, inhibiting the enzyme allosteri-
cally. It is widely believed that NNRTIs function as ‘‘molecular wedges’’,
disrupting the region between thumb and palm subdomains of the p66 subunit
and locking the thumb in a wide open conformation. Crystal structure data sug-
gests that the binding of NNRTIs forces RT into a wide open conformation in
which the separation is between the thumb and fingers subdomains is much
higher that the apo structure. Using multi-copy molecular dynamics simula-
tions (with a cumulative simulation time of approximately 900 ns) we have cap-
tured RT bound to the NNRTI efavirenz in a previously uncharacterised closed
conformation suggesting that the constraint of thumb motion is not as complete
as previously believed. This conformation is similar to that adopted by the apo
enzyme but with a modified inter-subdomain hinge. We compare the correlated
domain motions of the drug bound and apo enzymes. A more detailed under-
standing of the mechanism of NNRTI inhibition and the effect of their binding
upon domain motion could aid the design of more effective inhibitors and help
identify novel allosteric sights.
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Dioxygenases are bacterial nonheme iron enzymes responsible for the aerobic
catabolism of several intermediates produced by the decomposition of aromatic
compounds that are industrially released in the environment and recalcitrant to
Sunday, February 26, 2012 65abiodegradation. Their paramount role in the degradation of toxic substances is
the main interest in studying their mechanism of action. Pp 1,2-CCD belongs to
the intradiol dioxygenase family, whose structures of its members have been
only recently determined. In all those structures, an unexpected and interesting
feature came up: electron density for two phospholipid molecules was found at
the dimer interface, bringing up issues related to the relevance of those amphi-
patic molecules to enzyme catalysis. In this work, we present a series of
results from our group focused on the characterization of the phospholipid
binding and also on its role in enzyme function. We investigate, using a combi-
nation of experimental techniques (ESR, DSC, ITC, CD, UV-Vis absorbance),
Pseudomonas putida chlorocatechol 1,2-dioxygenase (Pp 1,2-CCD) before
and after delipidation procedures. Our results show that: (1) Fe(III) ion is
converted to Fe(II) during catalysis and that this iron site in not influenced
by the presence/absence of the phospholipid molecules; (2) Pp 1,2-CCD does
not interact with several lipid model membranes; (3) delipidated Pp 1,2-CCD
presents a cooperative kinetics, thus differing from lipid-containing Pp
1,2-CCD, which follows a usual Michaelis-Menten kinetics; (4) the product
of the catalysis is capable of inhibiting the reaction; (5) delipidation leads
to a somewhat more stable enzyme, with higher thermal-transition temperature
and enthalpy. We discuss those findings in terms of Pp 1,2-CCD crystal struc-
ture that we have recently determined. These results, although regarding more
fundamental aspects of the activity, shed light on features of Pp 1,2-CCD func-
tion that can be relevant towards its use in bioremediation/biotechnological
processes.
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Apolipoprotein A-I (ApoA-I) is the primary protein component of high density
lipoproteins (HDL). ApoA-I plays an important role in cholesterol metabolism
by mediating the formation of nascent HDL and the efflux of cellular choles-
terol from macrophage foam cells in arterial walls. Lipidation of ApoA-I is
mediated by the ATP-binding cassette A1 (ABCA1). Insufficient ABCA1 ac-
tivity my lead to reduced HDL formation, reduced cholesterol efflux and the
development of arteriosclerosis.
The standard radioactive assay for measuring cholesterol transport to lipid-free
ApoA-I has low through-put, poor dynamic range and fails to measure phos-
pholipid transferred with cholesterol. We describe the development of two
sensitive, non-radioactive high-throughput assays that report on the lipidation
state of ApoA-I and may have applications for studying ABCA1 function
and HDL metabolism: a homogenous assay based on the Time Resolved
FRET (TR-FRET) and a discontinuous assay that uses the Epic.
The TR-FRET assay employs a fluorescent ApoA-I where Cysteine is labeled
with the FRET acceptor HiLyte-Fluor-647 and an N-terminal Biotin-AviTag is
bound to the streptavidin-Terbium conjugate. When this ApoA-I was incorpo-
rated into recombinant HDL, TR-FRET decreased proportionally to the in-
crease in the ratio of lipid to ApoA-I in agreement with the expansion of the
surface area of lipids concomitant with the increase in separation of N-terminal
and central regions of the protein and demonstrated that the HTRF assay was
sensitive to the amount of lipid associated with ApoA-I.
The Epic is a label-free platform that allows for the observation of direct bio-
molecular interactions via a resonant wavelength shift which is proportional to
the mass bound to the surface. In the Epic assay, biotinylated ApoA-I was cap-
tured on streptavidin-coated sensor. The response was proportional to the
amount of lipids associated with ApoA-I indicating that the assay could sense
lipidation of ApoA-I.
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During infection, the redox activity of cell-free Hb is augmented upon its in-
teraction with bacterial lipopolysaccharide (LPS). The free radicals thus gen-
erated contribute to the innate immune defense of the host. Despite theimportance of Hb-LPS interactions, their interaction sites have not been elu-
cidated. Here, we mapped LPS-binding sites on Hb using a systematic ap-
proach of computational predictions and empirical validations. Surface
plasmon resonance (SPR) analysis showed LPS-binding activities present on
both the Hb-a and -b subunits, indicative of multiple interaction sites on
the tetrameric Hb. Since the diphosphorylglucosamine head group of LPS is
known to bind avidly to LPS-binding proteins, we applied a propensity com-
putation algorithm to predict phospho-group binding sites on Hb. Evolution-
arily conserved binding sites were identified by analysis of structure-based
sequence alignments of Hbs. Eight LPS-binding sites were determined by li-
gand docking to the conserved, high propensity sites followed by a comparison
of their binding energies. Based on the in silico predictions, synthetic Hb pep-
tides were designed for experimental validations. True positive LPS-binding
peptides were identified by SPR and further confirmed using a fluorescent
probe displacement assay. Flow cytometry and scanning electron microcopy
using Gram-negative bacteria showed that a peptide comprising residues
59-95 of Hbb associated with the bacterial surface, probably via LPS. The
LPS-binding property of the Hb peptides was corroborated by mutational anal-
ysis of Hb subunits. Lysine to aspartate mutations were introduced at positions
56, 60 and 61 in Hba, and positions 59, 66 and 95 in Hbb. Mutations led to
two-fold and four-fold drops in LPS-binding activities of the Hb-a and -b sub-
units, respectively. The experimental results, together with the molecular
modeling, have thus delineated LPS-binding regions on the Hb tetramer,
and this finding has potential application for the development of antimicrobial
therapeutics.
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Serum Albumin (SA) is one of the transport proteins which were discovered in
plasma. SA have chiral environment where bind to various molecules such as
organic molecule, amid acid, metal ion etc. Delivering 1,1’-bi-2-naphthol (Bi-
nol) by drops into Bovine Serum Albumin (BSA) and Human Serum Albumin
(HSA) shows red shift upon absorption spectra and induced circular dichroism
upon circular dichroism spectra over the 300 nm wavelength range and induced
chirality.[1] Furthermore, (S)-Binol had more selectivity than (R)-Binol in bind-
ing to SA. Irradiating at 365 nm, Binol is photoinversed in high enantiomeric
excess (ee) in the presence of BSA or HSA. Achiral 2-Anthracenecarboxylica-
cid (AC) is induced chirality in the presence of various SA.[2] As in the case of
Binol and SA complexes, AC and SA complexes undergo photocyclodimeriza-
tion in high ee.Moreover, the movement of AC in 2nd and 3rd site of HSA was
observed.
In this study, we measured Brownian motion on biological supramolecular
reaction using Diffracted X-ray Tracking (DXT) at beam lines of NW14A,
PF-AR and BL40XU, SPring8. We tracked diffracted spots from gold nano-
crystals (450-80 nm) labeled on each SA as host in real time. We also used
Quartz Crystal Microbalance (QCM) and Dynamic Light Scattering (DLS) to
explore the size of complexes. We measured motions of Binol within SA
and AC within SA in various conditions such as presence of laser irradiation
or varied composition ratio upon complexes. in this presentation, we report
the dynamics of photoinduced biological supramolecular reaction in SA with
Binol and AC.
[1] N. Levi-Miniz and M. Zandomeneghi, J. Am. Chem. Soc. 114, 9300 (1992).
[2] M, Nishijima; T, Wada; T, Mori; T, C. S. Pace; C, Bohne; Y, Inoue, J. Am.
Chem. Soc. 2007, 129, 3478.
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Irvalec (PM02734, Elisidepsin) is a marine-derived cytotoxic depsipeptide
that is currently undergoing phase II clinical studies in non-small cell lung
